|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,250,000,000 |
Market
Cap: |
91.01(B) |
Last
Volume: |
18,277,023 |
Avg
Vol: |
12,077,193 |
52
Week Range: |
$40.25 - $64.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 97 |
Guru Rank Value : 8.6 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
0 |
0 |
18,718 |
616,397 |
Total Sell Value |
$0 |
$0 |
$1,146,397 |
$44,859,834 |
Total People Sold |
0 |
0 |
2 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
11 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gordon Murdo |
SVP, Head of Worldwide Markets |
|
2015-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
205 |
|
- |
|
Judge Ann Powell |
SVP, Global Human Resources |
|
2015-04-01 |
4 |
D |
$63.56 |
$44,492 |
D/D |
(700) |
8,347 |
|
- |
|
Judge Ann Powell |
SVP, Global Human Resources |
|
2015-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,554 |
9,047 |
|
- |
|
Cornelius James M |
Director |
|
2015-03-31 |
4 |
A |
$64.50 |
$24,962 |
D/D |
387 |
79,851 |
|
- |
|
Cuss Francis M |
EVP & CSO |
|
2015-03-16 |
4 |
S |
$67.81 |
$7,775,501 |
D/D |
(114,666) |
266,033 |
|
- |
|
Cuss Francis M |
EVP & CSO |
|
2015-03-16 |
4 |
OE |
$24.74 |
$2,909,160 |
D/D |
114,010 |
380,699 |
|
- |
|
Schmukler Louis S |
Pres., Global Mfg. & Supply |
|
2015-03-16 |
4 |
S |
$67.08 |
$469,560 |
D/D |
(7,000) |
22,218 |
|
- |
|
Schmukler Louis S |
Pres., Global Mfg. & Supply |
|
2015-03-13 |
4 |
S |
$66.79 |
$333,972 |
D/D |
(5,000) |
29,218 |
|
- |
|
Moed Samuel J |
SVP, Strat Plan & Analysis |
|
2015-03-13 |
4 |
S |
$66.67 |
$39,402 |
D/D |
(591) |
31,015 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-03-10 |
4/A |
D |
$65.53 |
$531,645 |
D/D |
(8,113) |
160,857 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-03-10 |
4/A |
A |
$0.00 |
$0 |
D/D |
4,781 |
164,254 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-03-10 |
4/A |
OE |
$0.00 |
$0 |
D/D |
13,239 |
163,538 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-10 |
4/A |
D |
$65.53 |
$2,509,471 |
D/D |
(38,295) |
570,074 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-10 |
4/A |
A |
$0.00 |
$0 |
D/D |
19,740 |
583,175 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-10 |
4/A |
OE |
$0.00 |
$0 |
D/D |
48,850 |
580,947 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-10 |
4 |
D |
$65.53 |
$2,509,471 |
D/D |
(38,295) |
400,858 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,740 |
413,959 |
|
- |
|
Andreotti Lamberto |
Chief Executive Officer |
|
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
48,850 |
411,731 |
|
- |
|
Judge Ann Powell |
SVP, Human Resources |
|
2015-03-10 |
4 |
D |
$65.53 |
$122,213 |
D/D |
(1,865) |
7,493 |
|
- |
|
Judge Ann Powell |
SVP, Human Resources |
|
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,592 |
8,313 |
|
- |
|
Judge Ann Powell |
SVP, Human Resources |
|
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,546 |
8,057 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-03-10 |
4 |
D |
$65.53 |
$463,101 |
D/D |
(7,067) |
305,139 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,631 |
308,072 |
|
- |
|
Leung Sandra |
General Counsel & Secretary |
|
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,997 |
307,535 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2015-03-10 |
4 |
D |
$65.53 |
$531,645 |
D/D |
(8,113) |
181,609 |
|
- |
|
953 Records found
|
|
Page 32 of 39 |
|
|